Prevention of bone loss in paraplegics over 2 years with alendronate. - Wikidata - wikimedia - TriplyDB

Prevention of bone loss in paraplegics over 2 years with alendronate.

Prevention of bone loss in paraplegics over 2 years with alendronate.

http://www.wikidata.org/entity/Q44920759

about

Chronic complications of spinal cord injury Evidence-based prevention and treatment of osteoporosis after spinal cord injury: a systematic review.Loading and skeletal development and maintenance Bone health in patients with multiple sclerosis.Effectiveness of bisphosphonate analogues and functional electrical stimulation on attenuating post-injury osteoporosis in spinal cord injury patients- a systematic review and meta-analysis.The effect of low-magnitude whole body vibration on bone density and microstructure in men and women with chronic motor complete paraplegia.Association between alendronate, serum alkaline phosphatase level, and heterotopic ossification in individuals with spinal cord injury.Physiatrists' opinions and practice patterns for bone health after SCI.Evaluation of bone mineral density in patients with spinal cord injury.Prevention and Treatment of Bone Loss after a Spinal Cord Injury: A Systematic Review.A comprehensive study of long-term skeletal changes after spinal cord injury in adult rats.Bone loss in spinal cord-injured patients: from physiopathology to therapy.Spinal cord injury-induced osteoporosis: pathogenesis and emerging therapies.Measurement of Bone: Diagnosis of SCI-Induced Osteoporosis and Fracture Risk Prediction.Mechanisms of osteoporosis in spinal cord injury.Barriers to providing dual energy x-ray absorptiometry services to individuals with spinal cord injury.Osteoporotic fractures and hospitalization risk in chronic spinal cord injury.Bisphosphonate use in acute and chronic spinal cord injury: a systematic review.VA-based survey of osteoporosis management in spinal cord injury Long-term follow-up of patients with spinal cord injury with a new ICF-based tool.Long-bone fractures in persons with spinal cord injury.Changes of basic bone turnover parameters in short-term and long-term patients with spinal cord injury.The generation of loads in excess of the osteogenic threshold by physical movement.Effect of alendronate on bone mineral density in spinal cord injury patients: a pilot study.Analysis of the evolution of cortical and trabecular bone compartments in the proximal femur after spinal cord injury by 3D-DXA.Strontium ranelate prevents bone loss in a rat model of localized muscle paralysis.Treatment With a Soluble Bone Morphogenetic Protein Type 1A Receptor (BMPR1A) Fusion Protein Increases Bone Mass and Bone Formation in Mice Subjected to Hindlimb Unloading

P2860

Q27021713-DA4EA53B-DA7D-41D1-B50F-26B834B80619 Q30234487-4D9E71C3-0175-4F67-8ABB-85DF894C18DD Q34442741-2AD7215C-A436-4AB9-811F-B34522678DE6 Q34986532-E802B07D-16BF-40FC-8989-F81473A01BEE Q35053896-EC84D38D-5248-4292-85E1-F24549EB9460 Q35418541-47907105-B81D-4980-888D-CD198A35DCB5 Q35418599-FDCD16A5-7E65-43DE-AE5E-CF7D84C50D7B Q35580815-6EF4EFE3-2758-4866-B61D-61C10DF42FB8 Q35781307-E5C9444F-7381-46AE-B3C6-B0293CA87A27 Q36073958-6074DE89-E0E1-45A9-861A-65625DB4EFC9 Q36209428-A56060FD-ED1A-4A4A-8AE1-F6D049659D69 Q36255761-C0960D97-9C91-474A-B6EF-874F4F01C3AA Q36428144-3601F632-57A6-41DA-988E-C39DC8A06DBF Q36572362-9CDA3B44-9559-46F5-8501-D6B1248137A8 Q36630034-68762BAA-287B-4BA1-9C56-0AC28A7D09FB Q37021130-93077F0F-A9B0-4979-AEF3-AE80AEAC85D7 Q37093063-93465686-3923-450B-A05E-5CA9E5CD74FF Q37283878-6A5E3193-15BB-424E-BB7B-A00985B0F396 Q37470039-117C5638-D810-4965-9546-AFA152F97E9F Q39846952-64BB641B-B622-4B26-82F7-08BEDB85483A Q40926280-968526FE-E137-491E-A184-25F93A5B916C Q42066038-3009AED9-FB16-4902-A7DE-38BA8D6AE2B1 Q44117404-57EC941D-9221-4626-953B-D40B6067B5FB Q45256740-60A89B26-9CC3-4E48-9536-2F467ACD3060 Q50085949-F9ADE262-113F-4E7E-9E33-7D8043FA2978 Q51368802-A0A9C615-4349-4311-AB32-1D1F329D2DAF Q57151981-B28052C8-C70F-428F-9507-85229E9B59FA

P2860

Prevention of bone loss in paraplegics over 2 years with alendronate.

http://www.wikidata.org/entity/Q44920759

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh

2004年學術文章

@zh-hant

name

Prevention of bone loss in paraplegics over 2 years with alendronate.

@en

Prevention of bone loss in paraplegics over 2 years with alendronate.

@nl

type

label

Prevention of bone loss in paraplegics over 2 years with alendronate.

@en

Prevention of bone loss in paraplegics over 2 years with alendronate.

@nl

prefLabel

Prevention of bone loss in paraplegics over 2 years with alendronate.

@en

Prevention of bone loss in paraplegics over 2 years with alendronate.

@nl

P1433

Q44920759-DABCD2E1-C89B-480E-9DC1-861A28E6C596

P1476

Q44920759-E4E0E30A-56A1-48FE-908F-6A5C1FA78047

P2093

Q44920759-23386C39-BC95-48ED-96A2-85AC61A42ECE

Q44920759-6B1D71B4-0538-417F-8419-35E1C6B23A23

Q44920759-75AD6704-ABE9-45E9-B4A3-C9CA63FB2A56

Q44920759-BA789494-C430-4E99-A8E4-F7A79761008D

Q44920759-C462FDAF-38D6-4C73-8813-A0D9CA3C9E93

Q44920759-CC43DD51-7009-4417-B6D3-0C54D98B81B7

Q44920759-E91F2DB2-3648-48B3-BDDF-A80F15B4FE9D

P2860

Q44920759-1E8F8965-E91B-424E-B764-90993B15B95A

Q44920759-2FD9A830-F9BE-4052-AAC0-FA888DA8F790

Q44920759-56EAD4A8-AF85-4757-A05E-B9A7856F310D

Q44920759-BB5614F7-2135-4C4C-878B-E1A6AD2C8DE8

Q44920759-EAC36829-0CC6-4FCF-900C-65FA10F1A230

P304

Q44920759-CB5CA974-B9A9-43D2-8D13-F45D74E4F9D4

P31

Q44920759-086DAD24-099C-4905-A85F-497DCCD59A83

P356

Q44920759-F3BA1A18-2B34-4A3B-A658-2D6D586E2DFF

P433

Q44920759-6A4F3585-F2B6-4AE2-90B8-BCD3D44483B9

P478

Q44920759-DD149C0D-29DE-4B7D-99EE-878CE7F1E8E7

P50

Q44920759-C4CC5B94-98F5-4593-9F6C-45B0A66D62B0

P577

Q44920759-6E5A33D8-2724-43D8-9103-152213873642

P698

Q44920759-27660D34-B782-478C-BA3B-3883B8604255

P356

P1433

Journal of Bone and Mineral Research

P1476

Prevention of bone loss in paraplegics over 2 years with alendronate.

@en

P2093

Dieter Michel

http://www.w3.org/2001/XMLSchema#string

Guido A Zäch

http://www.w3.org/2001/XMLSchema#string

Hans Knecht

http://www.w3.org/2001/XMLSchema#string

Marius Kraenzlin

http://www.w3.org/2001/XMLSchema#string

Romain Perrelet

http://www.w3.org/2001/XMLSchema#string

Simone Risi

http://www.w3.org/2001/XMLSchema#string

Yvonne Zehnder

http://www.w3.org/2001/XMLSchema#string

P2860

Immobilization osteoporosis in paraplegia.

Longitudinal study of calcium and bone metabolism in paraplegic patients.

Reduction of hypercalciuria in tetraplegia after weight-bearing and strengthening exercises.

The physiological benefits of paraplegic orthotically aided walking.

Clinical investigation of bone metabolism in spinal cord lesions.

P304

1067-1074

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1359/JBMR.040313

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P50

P577

2004-03-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15176988

http://www.w3.org/2001/XMLSchema#string